Skip to content
10-K

Annual Report

CHINA-BIOTICS, INC

0001144204-13-030858

← back to feed
Filed
May 21, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2010 · Mar 31, 2011 23.69M sh
Shares Diluted FY 2010 · Mar 31, 2010 19.61M sh
Shares Diluted FY 2010 · Mar 31, 2009 17.08M sh
Shares Outstanding FY 2010 · Mar 31, 2011 22.15M sh
Capex FY 2010 · Mar 31, 2011 $0
Capex FY 2010 · Mar 31, 2010 $0
Capex FY 2010 · Mar 31, 2009 $808.22K
Operating Cash Flow restated FY 2010 · Mar 31, 2011 $25.79M
Operating Cash Flow FY 2010 · Mar 31, 2010 $29.53M
Operating Cash Flow FY 2010 · Mar 31, 2009 $23.64M
Current Liabilities FY 2010 · Mar 31, 2011 $41.29M
Current Liabilities FY 2010 · Mar 31, 2010 $76.76M
Current Assets FY 2010 · Mar 31, 2011 $173.56M
Current Assets FY 2010 · Mar 31, 2010 $181.95M
Total Assets FY 2010 · Mar 31, 2011 $237.63M
Total Assets FY 2010 · Mar 31, 2010 $232.93M
Eps Diluted restated FY 2010 · Mar 31, 2011 $1.02
Eps Diluted FY 2010 · Mar 31, 2010 $0.80
Eps Diluted FY 2010 · Mar 31, 2009 $1.17
Eps Basic FY 2010 · Mar 31, 2011 $1.66
Eps Basic FY 2010 · Mar 31, 2010 $0.80
Eps Basic FY 2010 · Mar 31, 2009 $1.17
Sga Expense restated FY 2010 · Mar 31, 2011 $13.5M
Sga Expense FY 2010 · Mar 31, 2010 $4.87M
Sga Expense FY 2010 · Mar 31, 2009 $3.02M
Rd Expense FY 2010 · Mar 31, 2011 $6.73M
Rd Expense FY 2010 · Mar 31, 2010 $3.67M
Rd Expense FY 2010 · Mar 31, 2009 $3.23M
Net Income FY 2010 · Mar 31, 2011 $36.94M
Net Income FY 2010 · Mar 31, 2010 $15.65M
Net Income FY 2010 · Mar 31, 2009 $19.97M
Operating Income FY 2010 · Mar 31, 2011 $35.73M
Operating Income FY 2010 · Mar 31, 2010 $35.28M
Operating Income FY 2010 · Mar 31, 2009 $21.78M
Gross Profit FY 2010 · Mar 31, 2011 $69.87M
Gross Profit FY 2010 · Mar 31, 2010 $57.29M
Gross Profit FY 2010 · Mar 31, 2009 $38M
Cost Of Revenue FY 2010 · Mar 31, 2011 $38.93M
Cost Of Revenue FY 2010 · Mar 31, 2010 $24.07M
Cost Of Revenue FY 2010 · Mar 31, 2009 $16.2M
Cash And Equivalents restated FY 2010 · Mar 31, 2010 $155.58M
Cash And Equivalents FY 2010 · Mar 31, 2009 $70.82M
Cash And Equivalents FY 2010 · Mar 31, 2008 $64.31M
Stockholders Equity FY 2010 · Mar 31, 2010 $156.18M
Stockholders Equity FY 2010 · Mar 31, 2009 $65.4M
Stockholders Equity FY 2010 · Mar 31, 2008 $44.4M